Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3726)
All Articles published online
|
Aug 28, 2010 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Treekitkarnmongkol W, Suthiphongchai T. High expression of ErbB2 contributes to cholangiocarcinoma cell invasion and proliferation through AKT/p70S6K. World J Gastroenterol 2010; 16(32): 4047-4054 [PMID: 20731018 DOI: 10.3748/wjg.v16.i32.4047] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i32/4047.htm |
| Number | Citing Articles |
| 1 |
Xiao-Nan Zhang, Ya Gao, Xi-Ya Zhang, Ning-Jie Guo, Wen-Qing Hou, Shu-Wu Wang, Yi-Chao Zheng, Ning Wang, Hong-Min Liu, Bo Wang. Detailed curriculum vitae of HER2-targeted therapy. Pharmacology & Therapeutics 2023; 245: 108417 doi: 10.1016/j.pharmthera.2023.108417
|
| 2 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 3 |
Wook Jin. ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications. Journal of Clinical Medicine 2020; 9(7): 2255 doi: 10.3390/jcm9072255
|
| 4 |
Vivek Mishra, Kausar M. Ansari, Raj Khanna, Mukul Das. Role of ErbB2 mediated AKT and MAPK pathway in gall bladder cell proliferation induced by argemone oil and butter yellow. Cell Biology and Toxicology 2012; 28(3): 149 doi: 10.1007/s10565-011-9207-5
|
| 5 |
Saumya Jayakumar, Mary Lee Krinsky. Encyclopedia of Gastroenterology. 2020; : 470 doi: 10.1016/B978-0-12-801238-3.65865-8
|
| 6 |
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
|
| 7 |
Keatdamrong Janpipatkul, Kanoknetr Suksen, Suparerk Borwornpinyo, Natee Jearawiriyapaisarn, Suradej Hongeng, Pawinee Piyachaturawat, Arthit Chairoungdua. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration. Cellular Signalling 2014; 26(8): 1668 doi: 10.1016/j.cellsig.2014.04.002
|
| 8 |
Suman Dutta, Onrapak Reamtong, Wittaya Panvongsa, Sarunya Kitdumrongthum, Keatdamrong Janpipatkul, Polkit Sangvanich, Pawinee Piyachaturawat, Arthit Chairoungdua. Proteomics profiling of cholangiocarcinoma exosomes: A potential role of oncogenic protein transferring in cancer progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1989 doi: 10.1016/j.bbadis.2015.06.024
|
| 9 |
Marcello Moro Queiroz, Nildevande Firmino Lima, Tiago Biachi de Castria. Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza. Cancers 2023; 15(7): 1970 doi: 10.3390/cancers15071970
|
| 10 |
Ah-Rong Nam, Ji-Won Kim, Yongjun Cha, Hyerim Ha, Ji Eun Park, Ju-Hee Bang, Mei Hua Jin, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Do-Youn Oh, Yung-Jue Bang. Therapeutic implication of HER2 in advanced biliary tract cancer. Oncotarget 2016; 7(36): 58007 doi: 10.18632/oncotarget.11157
|
| 11 |
Laura Fouassier, Marco Marzioni, Marta B. Afonso, Steven Dooley, Kevin Gaston, Gianluigi Giannelli, Cecilia M. P. Rodrigues, Elisa Lozano, Serena Mancarella, Oreste Segatto, Javier Vaquero, Jose J. G. Marin, Cédric Coulouarn. Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance. Liver International 2019; 39(S1): 43 doi: 10.1111/liv.14102
|
| 12 |
Mairéad G. McNamara, Cristiane Metran-Nascente, Jennifer J. Knox. State-of-the-art in the management of locally advanced and metastatic gallbladder cancer. Current Opinion in Oncology 2013; 25(4): 425 doi: 10.1097/CCO.0b013e3283620fd8
|
| 13 |
Facai Yang, Yinghe Qiu, Bin Yi. Targeted mutation-based therapy for intrahepatic cholangiocarcinoma. Hepatoma Research 2023; doi: 10.20517/2394-5079.2023.68
|
| 14 |
Caterina Vivaldi, Lorenzo Fornaro, Clara Ugolini, Cristina Niccoli, Gianna Musettini, Irene Pecora, Andrea Cacciato Insilla, Francesca Salani, Giulia Pasquini, Silvia Catanese, Monica Lencioni, Gianluca Masi, Daniela Campani, Gabriella Fontantini, Alfredo Falcone, Enrico Vasile. HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer. The Oncologist 2020; 25(10): 886 doi: 10.1634/theoncologist.2019-0922
|
| 15 |
Giulia Ronchi, Giovanna Gambarotta, Federica Di Scipio, Paolina Salamone, Andrea E. Sprio, Federica Cavallo, Isabelle Perroteau, Giovanni N. Berta, Stefano Geuna, Guy Tear. ErbB2 Receptor Over-Expression Improves Post-Traumatic Peripheral Nerve Regeneration in Adult Mice. PLoS ONE 2013; 8(2): e56282 doi: 10.1371/journal.pone.0056282
|
| 16 |
Siriwat Sukphokkit, Pichamon Kiatwuthinon, Supeecha Kumkate, Tavan Janvilisri. Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localization. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.999158
|
| 17 |
Ye Hong, Xiaofen Li, Dan Cao. Case Report: Trastuzumab Treatment in Adenosquamous Carcinoma of the Extrahepatic Biliary Tract With Her-2 Amplification. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.538328
|
| 18 |
Giovanni N. Berta, Andrea E. Sprio, Manuela Iezzi, Michela Spadaro, Susanna Cappia, Paolina Salamone, Federica Di Scipio, Barbara Mognetti, Mauro Papotti, Piero Musiani, Guido Forni, Federica Cavallo. A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. Cancer Prevention Research 2011; 4(7): 994 doi: 10.1158/1940-6207.CAPR-10-0301
|
| 19 |
Mirella Pastore, Giulia Lori, Alessandra Gentilini, Maria Letizia Taddei, Giovanni Di Maira, Claudia Campani, Stefania Recalcati, Pietro Invernizzi, Fabio Marra, Chiara Raggi. Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives. Cells 2020; 9(3): 596 doi: 10.3390/cells9030596
|
| 20 |
Elisa Lozano, Maria J. Monte, Oscar Briz, Angel Hernández-Hernández, Jesus M. Banales, Jose J.G. Marin, Rocio I.R. Macias. Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT). Journal of Controlled Release 2015; 216: 93 doi: 10.1016/j.jconrel.2015.08.022
|
| 21 |
Elisa Lozano, Laura Sanchez-Vicente, Maria J. Monte, Elisa Herraez, Oscar Briz, Jesus M. Banales, Jose J.G. Marin, Rocio I.R. Macias. Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development. Molecular Cancer Research 2014; 12(1): 91 doi: 10.1158/1541-7786.MCR-13-0503
|
| 22 |
Hongsik Kim, Ryul Kim, Hye Ryeon Kim, Hyunji Jo, Hana Kim, Sang Yun Ha, Joon Oh Park, Young Suk Park, Seung Tae Kim. HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.834104
|
| 23 |
Apinya Jusakul, Ioana Cutcutache, Chern Han Yong, Jing Quan Lim, Mi Ni Huang, Nisha Padmanabhan, Vishwa Nellore, Sarinya Kongpetch, Alvin Wei Tian Ng, Ley Moy Ng, Su Pin Choo, Swe Swe Myint, Raynoo Thanan, Sanjanaa Nagarajan, Weng Khong Lim, Cedric Chuan Young Ng, Arnoud Boot, Mo Liu, Choon Kiat Ong, Vikneswari Rajasegaran, Stefanus Lie, Alvin Soon Tiong Lim, Tse Hui Lim, Jing Tan, Jia Liang Loh, John R. McPherson, Narong Khuntikeo, Vajaraphongsa Bhudhisawasdi, Puangrat Yongvanit, Sopit Wongkham, Yasushi Totoki, Hiromi Nakamura, Yasuhito Arai, Satoshi Yamasaki, Pierce Kah-Hoe Chow, Alexander Yaw Fui Chung, London Lucien Peng Jin Ooi, Kiat Hon Lim, Simona Dima, Dan G. Duda, Irinel Popescu, Philippe Broet, Sen-Yung Hsieh, Ming-Chin Yu, Aldo Scarpa, Jiaming Lai, Di-Xian Luo, André Lopes Carvalho, André Luiz Vettore, Hyungjin Rhee, Young Nyun Park, Ludmil B. Alexandrov, Raluca Gordân, Steven G. Rozen, Tatsuhiro Shibata, Chawalit Pairojkul, Bin Tean Teh, Patrick Tan. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Cancer Discovery 2017; 7(10): 1116 doi: 10.1158/2159-8290.CD-17-0368
|
| 24 |
Francesca Corti, Federico Nichetti, Alessandra Raimondi, Monica Niger, Natalie Prinzi, Martina Torchio, Elena Tamborini, Federica Perrone, Giancarlo Pruneri, Maria Di Bartolomeo, Filippo de Braud, Sara Pusceddu. Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews 2019; 72: 45 doi: 10.1016/j.ctrv.2018.11.001
|
| 25 |
Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisana Namwat, Tuangporn Suthiphongchai. Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48798-8
|
| 26 |
Pariyada Tanjak, Apinya Thiantanawat, Piyajit Watcharasit, Jutamaad Satayavivad. Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4375
|
| 27 |
Lisa Y. Law. Dramatic Response to Trastuzumab and Paclitaxel in a Patient With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Cholangiocarcinoma. Journal of Clinical Oncology 2012; 30(27): e271 doi: 10.1200/JCO.2012.42.3061
|
| 28 |
Chao Shang, Yan-ming Lu, Li-rong Meng. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Medical Science Monitor 2012; 18(4): BR149 doi: 10.12659/MSM.882617
|
| 29 |
Linger Liu, Yao Chen, Xiaolian Zhu, Lisha Zhao, Baisong Chen. HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case report. Anti-Cancer Drugs 2024; 35(3): 298 doi: 10.1097/CAD.0000000000001558
|